ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate - אבקה להכנת תרחיף - barium sulfate 96.476 %w/w - barium sulfate without suspending agents - barium sulfate without suspending agents - for rectal administration (enema) as a radio-opaque agent for x-ray visualisation of the lower gastro-intestinal tract. it is designed for both single contrast barium enema and air-double contrast enema usage.

ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate - אבקה להכנת תרחיף - barium sulfate 96 %w/w - barium sulfate with suspending agents - barium sulfate with suspending agents - single - contrast radiography of the oesophagus stomach duodenum and small bowel. for use only in x-ray departments.

ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate - אבקה להכנת תרחיף - barium sulfate 98.3845 %w/w - barium sulfate without suspending agents - barium sulfate without suspending agents - for double contrast radiography of the oesophagus, stomach and duodenum.

ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate - תרחיף - barium sulfate 4.9224 %w/v - barium sulfate containing x-ray contrast media - for use in x-ray departments.opacification of the gastro intestinal tract prior to computerized axial tomography.

ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate - תרחיף - barium sulfate 105 %w/v - barium sulfate containing x-ray contrast media - for use only in x-ray departments. single or double contrast radiographic visualization of the lower gastro intestinal tract.

ישראל - עברית - Ministry of Health

promedico ltd - barium sulfate 80.9977 %w/w - suspension - barium sulfate with suspending agents - radiolography of the gastro-intestinal tract. for use in x-ray departments.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 200 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei),serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.